Each N-PORT filing of FBT compared with the one before: positions added and dropped, the largest weight changes, turnover. Computed by Mulden from the filings; dated by filing period and SEC receipt.https://themulden.com/enhttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/31 positions became 31: 2 added (5.7% of the fund), 2 dropped (8.21%). Turnover proxy 18.2%. Largest increases: NEOGENOMICS INC 2% to 5.12%; VERACYTE INC 2.72% to 5.09%; BRUKER CORP 2.35% to 4.32%; CORCEPT THERAPEUTICS INC 3.82% to 5.59%; ILLUMINA INC 3.1% to 3.92%; NATERA INC 3.03% to 3.79%. Largest decreases: UNITED THERAPEUTICS CORP 4.36% to 2.56%; GILEAD SCIENCES INC 4.09% to 2.45%; REGENERON PHARMACEUTICALS INC 3.44% to 2.25%; AMGEN INC 3.83% to 2.78%; SAREPTA THERAPEUTICS INC 3.24% to 2.29%; BEONE MEDICINES LTD 3.12% to 2.48%. New: ARROWHEAD PHARMACEUTICALS INC (3.37%), ADMA BIOLOGICS INC (2.33%). Gone: Moderna Inc (5.26%), Acadia Pharmaceuticals Inc (2.95%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 21 Aug 2026 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/31 positions became 31: 3 added (8.71% of the fund), 3 dropped (11.77%). Turnover proxy 19.6%. Largest increases: Corcept Therapeutics Inc. 1.39% to 3.82%; Moderna Inc 3.25% to 5.26%; Alkermes PLC 2.65% to 4.23%; United Therapeutics Corporation 3.27% to 4.36%; Gilead Sciences Inc. 3.09% to 4.09%; Amgen Inc. 3.33% to 3.83%. Largest decreases: Bruker Corporation 3.95% to 2.35%; Illumina Inc 4.13% to 3.1%; Acadia Pharmaceuticals Inc 3.93% to 2.95%; NATERA INC 4% to 3.03%; Veracyte Inc 3.57% to 2.72%; Repligen Corporation 3.33% to 2.51%. New: Axsome Therapeutics Inc. (3.88%), Bio-Techne Corp (2.82%), Neogenomics Inc (2%). Gone: Exact Sciences Corp (5.14%), Waters Corp (3.39%), Mettler-Toledo International I (3.23%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 28 May 2026 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/31 positions became 31: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 11.9%. Largest increases: Exact Sciences Corp 3.27% to 5.14%; Bruker Corp 2.3% to 3.95%; Illumina Inc 2.97% to 4.13%; Regeneron Pharmaceuticals Inc 3.07% to 4.04%; Natera Inc 3.11% to 4%; Moderna Inc 2.38% to 3.25%. Largest decreases: Corcept Therapeutics Inc 3.59% to 1.39%; Alnylam Pharmaceuticals Inc 4.49% to 2.55%; Genmab A/S 4.45% to 2.86%; BeOne Medicines Ltd 4.23% to 2.8%; United Therapeutics Corp 4.4% to 3.27%; Argenx SE 4.09% to 3.12%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 23 Feb 2026 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/31 positions became 31: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 10.7%. Largest increases: Sarepta Therapeutics Inc 1.05% to 3.29%; Halozyme Therapeutics Inc 2.71% to 3.98%; Veracyte Inc 2.67% to 3.94%; United Therapeutics Corp 3.21% to 4.4%; Argenx SE 2.98% to 4.09%; Krystal Biotech Inc 2.62% to 3.7%. Largest decreases: ACADIA Pharmaceuticals Inc 4.64% to 3.16%; Neurocrine Biosciences Inc 4.34% to 3.27%; Exelixis Inc 3.92% to 2.86%; Illumina Inc 4.01% to 2.97%; Bruker Corp 3.34% to 2.3%; Moderna Inc 3.31% to 2.38%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 24 Nov 2025 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/31 positions became 31: 1 added (2.62% of the fund), 1 dropped (4.67%). Turnover proxy 17%. Largest increases: Illumina Inc 1.95% to 4.01%; Neurocrine Biosciences Inc 2.64% to 4.34%; ACADIA Pharmaceuticals Inc 3.23% to 4.64%; Exact Sciences Corp 2.57% to 3.75%; Moderna Inc 2.25% to 3.31%; Bruker Corp 2.31% to 3.34%. Largest decreases: Corcept Therapeutics Inc 7.69% to 3.36%; BeOne Medicines Ltd 5.17% to 3.3%; Halozyme Therapeutics Inc 4.06% to 2.71%; Vertex Pharmaceuticals Inc 3.98% to 2.89%; Amgen Inc 3.99% to 3.06%; Gilead Sciences Inc 4.19% to 3.36%. New: Krystal Biotech Inc (2.62%). Gone: Intra-Cellular Therapies Inc (4.67%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 26 Aug 2025 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/31 positions became 31: 1 added (2.4% of the fund), 1 dropped (3.55%). Turnover proxy 16.5%. Largest increases: Corcept Therapeutics Inc 3.82% to 7.69%; BeiGene Ltd 2.69% to 5.17%; Amgen Inc 2.73% to 3.99%; Vertex Pharmaceuticals Inc 2.88% to 3.98%; Alnylam Pharmaceuticals Inc 2.85% to 3.81%; Halozyme Therapeutics Inc 3.1% to 4.06%. Largest decreases: Sarepta Therapeutics Inc 3.36% to 1.72%; Natera Inc 4.19% to 2.71%; Neurocrine Biosciences Inc 4.07% to 2.64%; Illumina Inc 3.16% to 1.95%; ACADIA Pharmaceuticals Inc 4.23% to 3.23%; Exelixis Inc 4.37% to 3.44%. New: Veracyte Inc (2.4%). Gone: Catalyst Pharmaceuticals Inc (3.55%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 27 May 2025 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/31 positions became 31: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 8.9%. Largest increases: Neurocrine Biosciences Inc 2.42% to 4.07%; ACADIA Pharmaceuticals Inc 2.68% to 4.23%; Intra-Cellular Therapies Inc 2.91% to 3.79%; Sarepta Therapeutics Inc 2.55% to 3.36%; Exelixis Inc 3.59% to 4.37%; Moderna Inc 1.71% to 2.45%. Largest decreases: BeiGene Ltd 4.58% to 2.69%; Exact Sciences Corp 4.56% to 2.72%; BioNTech SE 4.34% to 3.25%; Corcept Therapeutics Inc 4.56% to 3.82%; Regeneron Pharmaceuticals Inc 2.96% to 2.41%; Mettler-Toledo International I 3.42% to 2.9%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 25 Feb 2025 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/31 positions became 31: 2 added (2.62% of the fund), 2 dropped (2.93%). Turnover proxy 14.3%. Largest increases: Exact Sciences Corp 1.88% to 4.56%; BioNTech SE 2.95% to 4.34%; BeiGene Ltd 3.21% to 4.58%; Repligen Corp 2.33% to 3.67%; Bruker Corp 2.31% to 3.31%; Waters Corp 2.85% to 3.69%. Largest decreases: Alnylam Pharmaceuticals Inc 5.2% to 3.27%; Moderna Inc 3.59% to 1.71%; Biogen Inc 3.71% to 2.61%; Halozyme Therapeutics Inc 4.31% to 3.34%; United Therapeutics Corp 4.35% to 3.46%; Neurocrine Biosciences Inc 3.25% to 2.42%. New: Sarepta Therapeutics Inc (2.55%), Dreyfus Government Cash Management (0.08%). Gone: Beam Therapeutics Inc (2.87%), Dreyfus Government Cash Management (0.07%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 25 Nov 2024 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/31 positions became 31: 3 added (9.05% of the fund), 3 dropped (9.6%). Turnover proxy 18.7%. Largest increases: Alnylam Pharmaceuticals Inc 2.55% to 5.2%; United Therapeutics Corp 3.46% to 4.35%; ACADIA Pharmaceuticals Inc 2.12% to 3.01%; Biogen Inc 2.87% to 3.71%; Corcept Therapeutics Inc 3.58% to 4.39%; Amgen Inc 3.06% to 3.71%. Largest decreases: Bruker Corp 4.35% to 2.31%; Exact Sciences Corp 3.4% to 1.88%; Natera Inc 4.96% to 3.64%; Repligen Corp 3.5% to 2.33%; Waters Corp 3.69% to 2.85%; Illumina Inc 3.28% to 2.68%. New: Catalyst Pharmaceuticals Inc (3.23%), BioNTech SE (2.95%), Beam Therapeutics Inc (2.87%). Gone: PTC Therapeutics Inc (3.51%), Insmed Inc (3.15%), Dynavax Technologies Corp (2.94%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 21 Aug 2024 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/30 positions became 31: 11 added (37.13% of the fund), 10 dropped (34.95%). Turnover proxy 39.6%. Largest increases: Argenx SE 2.35% to 3.48%; United Therapeutics Corp 2.86% to 3.46%; Mettler-Toledo International I 3.48% to 3.72%; Regeneron Pharmaceuticals Inc 3.18% to 3.4%; Exelixis Inc 3.33% to 3.45%; Alkermes PLC 3.06% to 3.17%. Largest decreases: ACADIA Pharmaceuticals Inc 4.14% to 2.12%; Alnylam Pharmaceuticals Inc 3.47% to 2.55%; BioMarin Pharmaceutical Inc 3.44% to 3.09%; Incyte Corp 3.34% to 3%; Moderna Inc 3.62% to 3.32%; Gilead Sciences Inc 3.05% to 2.8%. New: Natera Inc (4.96%), Bruker Corp (4.35%), Halozyme Therapeutics Inc (3.9%), Waters Corp (3.69%), Corcept Therapeutics Inc (3.58%), PTC Therapeutics Inc (3.51%). Gone: Ultragenyx Pharmaceutical Inc (4.23%), Grifols SA (4.19%), Charles River Laboratories Int (3.74%), IQVIA Holdings Inc (3.68%), Bio-Techne Corp (3.53%), BioNTech SE (3.4%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 24 May 2024 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/30 positions became 30: 1 added (3.06% of the fund), 1 dropped (3.92%). Turnover proxy 12.3%. Largest increases: ACADIA Pharmaceuticals Inc 2.43% to 4.14%; Ultragenyx Pharmaceutical Inc 2.97% to 4.23%; Grifols SA 3.16% to 4.19%; Illumina Inc 2.59% to 3.41%; Exact Sciences Corp 2.58% to 3.37%; Bio-Techne Corp 2.74% to 3.53%. Largest decreases: Sarepta Therapeutics Inc 4.12% to 2.54%; Amgen Inc 4.12% to 3.03%; Argenx SE 3.22% to 2.35%; Regeneron Pharmaceuticals Inc 4.03% to 3.18%; Ionis Pharmaceuticals Inc 4.01% to 3.21%; Exelixis Inc 3.99% to 3.33%. New: BEIGENE LTD (3.06%). Gone: Seagen Inc (3.92%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 23 Feb 2024 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/30 positions became 30: 1 added (3.22% of the fund), 1 dropped (0.46%). Turnover proxy 10.3%. Largest increases: Sarepta Therapeutics Inc 3.11% to 4.12%; Neurocrine Biosciences Inc 3.11% to 4.1%; Amgen Inc 3.15% to 4.12%; Regeneron Pharmaceuticals Inc 3.09% to 4.03%; Seagen Inc 3.25% to 3.92%; BioMarin Pharmaceutical Inc 3.08% to 3.63%. Largest decreases: Exact Sciences Corp 4.81% to 2.58%; ACADIA Pharmaceuticals Inc 4.12% to 2.43%; Agios Pharmaceuticals Inc 4.29% to 3.24%; Grifols SA 4.17% to 3.16%; Ultragenyx Pharmaceutical Inc 3.74% to 2.97%; IQVIA Holdings Inc 3.83% to 3.1%. New: Argenx SE (3.22%). Gone: FibroGen Inc (0.46%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 28 Nov 2023 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/30 positions became 30: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 9.2%. Largest increases: Agios Pharmaceuticals Inc 2.83% to 4.29%; Grifols SA 2.78% to 4.17%; Exact Sciences Corp 3.45% to 4.81%; Ionis Pharmaceuticals Inc 3.04% to 3.82%; ACADIA Pharmaceuticals Inc 3.38% to 4.12%; IQVIA Holdings Inc 3.09% to 3.83%. Largest decreases: FibroGen Inc 3.24% to 0.46%; Seagen Inc 5.35% to 3.25%; Illumina Inc 3.95% to 2.84%; Regeneron Pharmaceuticals Inc 3.95% to 3.09%; Sarepta Therapeutics Inc 3.67% to 3.11%; Exelixis Inc 4.03% to 3.47%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 18 Aug 2023 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/30 positions became 30: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 8.5%. Largest increases: Seagen Inc 2.95% to 5.35%; Illumina Inc 2.72% to 3.95%; Exelixis Inc 2.88% to 4.03%; Regeneron Pharmaceuticals Inc 2.99% to 3.95%; Vertex Pharmaceuticals Inc 2.84% to 3.53%; Ionis Pharmaceuticals Inc 2.48% to 3.04%. Largest decreases: Moderna Inc 4.14% to 2.75%; Grifols SA 4.13% to 2.78%; Exact Sciences Corp 4.45% to 3.45%; United Therapeutics Corp 3.75% to 2.97%; Alnylam Pharmaceuticals Inc 3.53% to 3.03%; BioMarin Pharmaceutical Inc 3.4% to 3.05%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 30 May 2023 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/30 positions became 30: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 11.9%. Largest increases: Exact Sciences Corp 2.45% to 4.45%; Grifols SA 2.15% to 4.13%; Moderna Inc 2.5% to 4.14%; Ultragenyx Pharmaceutical Inc 2.26% to 3.56%; Alkermes PLC 2.64% to 3.47%; United Therapeutics Corp 3.08% to 3.75%. Largest decreases: Ionis Pharmaceuticals Inc 3.98% to 2.48%; Agios Pharmaceuticals Inc 4.48% to 3.07%; Alnylam Pharmaceuticals Inc 4.86% to 3.53%; Biogen Inc 4.35% to 3.06%; Sarepta Therapeutics Inc 4.67% to 3.4%; Regeneron Pharmaceuticals Inc 4.01% to 2.99%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 23 Feb 2023 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/30 positions became 30: 1 added (3.31% of the fund), 1 dropped (2.32%). Turnover proxy 14.2%. Largest increases: Alnylam Pharmaceuticals Inc 3.28% to 4.86%; ACADIA Pharmaceuticals Inc 2.26% to 3.78%; Illumina Inc 2.06% to 3.56%; Agios Pharmaceuticals Inc 2.99% to 4.48%; Sarepta Therapeutics Inc 3.47% to 4.67%; Regeneron Pharmaceuticals Inc 3.04% to 4.01%. Largest decreases: Grifols SA 4.16% to 2.15%; Seagen Inc 4.45% to 2.71%; United Therapeutics Corp 4.63% to 3.08%; Alkermes PLC 3.82% to 2.64%; Exelixis Inc 3.4% to 2.6%; Moderna Inc 3.25% to 2.5%. New: Genmab A/S (3.31%). Gone: Nektar Therapeutics (2.32%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 25 Nov 2022 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/30 positions became 30: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 9.1%. Largest increases: United Therapeutics Corp 2.89% to 4.63%; Grifols SA 3.05% to 4.16%; Gilead Sciences Inc 2.79% to 3.77%; BioMarin Pharmaceutical Inc 2.93% to 3.76%; Seagen Inc 3.64% to 4.45%; Nektar Therapeutics 1.58% to 2.32%. Largest decreases: ACADIA Pharmaceuticals Inc 3.68% to 2.26%; Illumina Inc 3.07% to 2.06%; Exact Sciences Corp 3.04% to 2.13%; Ultragenyx Pharmaceutical Inc 3.48% to 2.63%; Exelixis Inc 4.21% to 3.4%; Bio-Techne Corp 3.8% to 3.12%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 19 Aug 2022 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/30 positions became 30: 1 added (3.02% of the fund), 1 dropped (3.01%). Turnover proxy 12.5%. Largest increases: Exelixis Inc 2.85% to 4.21%; Neurocrine Biosciences Inc 2.77% to 4.02%; Alnylam Pharmaceuticals Inc 2.77% to 3.85%; Ionis Pharmaceuticals Inc 2.95% to 3.99%; Alkermes PLC 2.5% to 3.53%; Moderna Inc 2.67% to 3.46%. Largest decreases: FibroGen Inc 4.35% to 2.8%; Nektar Therapeutics 2.66% to 1.58%; United Therapeutics Corp 3.93% to 2.89%; BioMarin Pharmaceutical Inc 3.96% to 2.93%; Gilead Sciences Inc 3.65% to 2.79%; ACADIA Pharmaceuticals Inc 4.54% to 3.68%. New: Mettler-Toledo International I (3.02%). Gone: Bluebird Bio Inc (3.01%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 26 May 2022 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/30 positions became 30: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 10.8%. Largest increases: ACADIA Pharmaceuticals Inc 2.35% to 4.54%; FibroGen Inc 2.37% to 4.35%; Vertex Pharmaceuticals Inc 2.98% to 4.11%; Incyte Corp 2.92% to 3.81%; Amgen Inc 2.85% to 3.69%; BioMarin Pharmaceutical Inc 3.26% to 3.96%. Largest decreases: Alkermes PLC 4.32% to 2.5%; Moderna Inc 4.46% to 2.67%; Exelixis Inc 4.18% to 2.85%; Nektar Therapeutics 3.7% to 2.66%; Sarepta Therapeutics Inc 4.58% to 3.64%; Seagen Inc 3.85% to 3.05%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 22 Feb 2022 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/30 positions became 30: 1 added (3.92% of the fund), 1 dropped (3.52%). Turnover proxy 11.5%. Largest increases: Exelixis Inc 2.42% to 4.18%; Sarepta Therapeutics Inc 3.39% to 4.58%; Nektar Therapeutics 2.83% to 3.7%; Ultragenyx Pharmaceutical Inc 2.75% to 3.51%; QIAGEN NV 2.88% to 3.63%; United Therapeutics Corp 2.76% to 3.32%. Largest decreases: FibroGen Inc 4.19% to 2.37%; ACADIA Pharmaceuticals Inc 3.62% to 2.35%; Bluebird Bio Inc 3.55% to 2.37%; Biogen Inc 4.02% to 2.9%; Illumina Inc 3.72% to 2.89%; Agios Pharmaceuticals Inc 3.16% to 2.74%. New: BioNTech SE (3.92%). Gone: Alexion Pharmaceuticals Inc (3.52%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 24 Nov 2021 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/30 positions became 30: 1 added (4.31% of the fund), 1 dropped (3.08%). Turnover proxy 12.2%. Largest increases: ACADIA Pharmaceuticals Inc 1.76% to 3.62%; Bluebird Bio Inc 2.19% to 3.55%; FibroGen Inc 2.94% to 4.19%; Alkermes PLC 3.06% to 3.87%; Alnylam Pharmaceuticals Inc 3.11% to 3.83%; Seagen Inc 2.74% to 3.4%. Largest decreases: Nektar Therapeutics 4.32% to 2.83%; Exelixis Inc 3.49% to 2.42%; Agios Pharmaceuticals Inc 4.14% to 3.16%; United Therapeutics Corp 3.54% to 2.76%; Amgen Inc 3.71% to 2.99%; Bio-Techne Corp 4.02% to 3.37%. New: Moderna Inc (4.31%). Gone: Intercept Pharmaceuticals Inc (3.08%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 19 Aug 2021 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/30 positions became 30: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 8.9%. Largest increases: Nektar Therapeutics 3.16% to 4.32%; Biogen Inc 2.78% to 3.72%; Intercept Pharmaceuticals Inc 2.26% to 3.08%; Regeneron Pharmaceuticals Inc 2.56% to 3.34%; Gilead Sciences Inc 2.99% to 3.74%; Exelixis Inc 2.75% to 3.49%. Largest decreases: ACADIA Pharmaceuticals Inc 3.99% to 1.76%; Ultragenyx Pharmaceutical Inc 4.79% to 3.02%; Ionis Pharmaceuticals Inc 3.82% to 2.69%; Sarepta Therapeutics Inc 3.81% to 3.02%; Exact Sciences Corp 4.08% to 3.31%; United Therapeutics Corp 4.2% to 3.54%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 25 May 2021 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/30 positions became 30: 1 added (2.78% of the fund), 1 dropped (4.03%). Turnover proxy 13%. Largest increases: Agios Pharmaceuticals Inc 2.45% to 3.84%; BioMarin Pharmaceutical Inc 2.23% to 3.52%; Ultragenyx Pharmaceutical Inc 3.59% to 4.79%; ACADIA PHARMACEUTICALS INC 2.82% to 3.99%; United Therapeutics Corp 3.24% to 4.2%; Ionis Pharmaceuticals Inc 2.87% to 3.82%. Largest decreases: Charles River Laboratories Int 4.33% to 3.31%; Biogen Inc 3.78% to 2.78%; Exelixis Inc 3.73% to 2.75%; Intercept Pharmaceuticals Inc 3.19% to 2.26%; QIAGEN NV 4.08% to 3.22%; FibroGen Inc 3.4% to 2.56%. New: Seagen Inc (2.78%). Gone: Seattle Genetics Inc (4.03%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 19 Feb 2021 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/30 positions became 30: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 8.8%. Largest increases: Biogen Inc 2.36% to 3.78%; Intercept Pharmaceuticals Inc 1.78% to 3.19%; QIAGEN NV 3.19% to 4.08%; Charles River Laboratories Int 3.63% to 4.33%; Grifols SA 2.64% to 3.31%; Amgen Inc 3.03% to 3.7%. Largest decreases: BioMarin Pharmaceutical Inc 4.18% to 2.23%; Agios Pharmaceuticals Inc 3.56% to 2.45%; Nektar Therapeutics 3.6% to 2.56%; Neurocrine Biosciences Inc 3.73% to 2.77%; Sarepta Therapeutics Inc 4.09% to 3.15%; Illumina Inc 3.54% to 3.03%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 24 Nov 2020 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/30 positions became 30: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 10.8%. Largest increases: Bluebird Bio Inc 1.81% to 3.31%; Ultragenyx Pharmaceutical Inc 2.86% to 4.04%; Sarepta Therapeutics Inc 2.95% to 4.09%; Exact Sciences Corp 2.54% to 3.52%; Agios Pharmaceuticals Inc 2.59% to 3.56%; Alkermes PLC 2.89% to 3.58%. Largest decreases: Biogen Inc 4.28% to 2.36%; Gilead Sciences Inc 4.58% to 2.77%; Regeneron Pharmaceuticals Inc 4.88% to 3.31%; QIAGEN NV 4.49% to 3.19%; ACADIA PHARMACEUTICALS INC 3.75% to 3%; Vertex Pharmaceuticals Inc 3.9% to 3.24%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 21 Aug 2020 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/30 positions became 30: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 8.8%. Largest increases: Gilead Sciences Inc 2.82% to 4.58%; Regeneron Pharmaceuticals Inc 3.52% to 4.88%; QIAGEN NV 3.34% to 4.49%; United Therapeutics Corp 3.02% to 3.93%; ACADIA PHARMACEUTICALS INC 3.02% to 3.75%; Biogen Inc 3.8% to 4.28%. Largest decreases: Intercept Pharmaceuticals Inc 5.36% to 2.29%; Agios Pharmaceuticals Inc 4.07% to 2.59%; Sarepta Therapeutics Inc 4.24% to 2.95%; Bluebird Bio Inc 2.76% to 1.81%; IQVIA Holdings Inc 3.03% to 2.58%; Nektar Therapeutics 3.52% to 3.06%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 26 May 2020 12:00:00 GMThttps://themulden.com/funds/fbt/https://themulden.com/funds/fbt/30 positions became 30: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 8.9%. Largest increases: Sarepta Therapeutics Inc 1.86% to 4.24%; Intercept Pharmaceuticals Inc 3.57% to 5.36%; Agios Pharmaceuticals Inc 2.56% to 4.07%; Nektar Therapeutics 2.1% to 3.52%; BioMarin Pharmaceutical Inc 3.05% to 3.44%; Bluebird Bio Inc 2.45% to 2.76%. Largest decreases: ACADIA PHARMACEUTICALS INC 5.17% to 3.02%; United Therapeutics Corp 3.91% to 3.02%; Illumina Inc 3.83% to 3.02%; Gilead Sciences Inc 3.6% to 2.82%; Neurocrine Biosciences Inc 3.88% to 3.16%; Amgen Inc 4% to 3.35%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 25 Feb 2020 12:00:00 GMT